Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos


Oral and Poster Abstracts Oral 906. Outcomes Research—Myeloid Malignancies: Health Equity and Disparities Adults, Access To Care, Study Population, Diversity, Equity, and Inclusion (DEI), Racial Inequities Mycal Casey, DO, MPH1*, Monirul Islam, MD, PhD2*, Mahran Shoukier, MD3*, Lorriane Odhiambo, PhD2* and Jorge E. Cortes, MD31Internal...

  • 123456 Profile photo of Madelyn

    This is a very interesting retrospective study were they looked at malignant hematology clinical trials between 2017 and 2021 which led to FDA drug approval and compared the demographics of the trial to those found in the SEER database. African Americans had an 86.5% lower percent representation in multiple myeloma and 68% lower in AML.